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This study demonstrates that gene-gun inoculation of mice with DNA encoding the influenza virus hemagglutinin (HA)
results in the life-long maintenance of protective B cell responses. Using a sensitive single-cell enzyme-linked immunospot
assay, we show that all of the HA-specific plasma cells are localized in the bone marrow and spleen 1 year postimmunization.
As a consequence of prior virus challenge, only a small population of antibody-forming cells was found in the lymphoid
tissues associated with the respiratory tract. The tissue distribution of HA-specific plasma cells in these mice was identical
to the profile in infected controls. Complete protection against live virus challenge in the aged vaccinated mice did not
require prior exposure to virus. Thus, immunization with the DNA vaccine provides long-term protective immunity against
otherwise lethal infection. q 1996 Academic Press, Inc.
INTRODUCTION yet little attention has been given to the longevity of the
immunity established by DNA vaccines.
Nucleic acid vaccination with naked plasmid DNA en- We have addressed this issue by using a murine influ-
coding specific antigens and delivered with or without enza virus model system and intradermal gene-gun deliv-
the aid of a gene gun (Cheng et al., 1993; Davis et al., ery of a nucleic acid vector that encodes the influenza
1994; Eisenbraun et al., 1993; Pertmer et al., 1995; Tang virus hemagglutinin (HA DNA). Specifically, we wished
et al., 1992; Zhu et al., 1993) offers a novel and promising to learn whether antibody production is maintained long-
means to induce immunity against several important term, to determine the anatomical sites of AFC popula-
pathogens, including influenza viruses (Fuller and tions, and to assess the ability of memory B cells to
Haynes, 1994; Fynan et al., 1993, 1995; Raz et al., 1994; respond to lethal virus challenges, based on the distribu-
Ulmer et al., 1993). The efficiency of any antiviral vaccine tion and immunoglobulin (Ig) isotype patterns of AFCs.
depends on the generation of a large population of mem- The results indicate the persistence of HA-specific AFCs
ory B cells and the maintenance of a high titer of neu- for as long as 1 year in the bone marrow and spleens
tralizing antibody (Ada, 1991), as well as the longevity of of mice immunized with HA DNA. Repeated challenges
the immunity induced (Doherty et al., 1992; Lipscomb et did not affect the long-term stability of these immunoglob-
al., 1995). ulin G (IgG)-producing cell populations, but invariably
The maintenance of antibody-forming cells (AFCs) in generated a prominant AFC population in the regional
the bone marrow has recently been shown to be the lymph nodes that drain the lungs within a week of chal-
primary means by which acute viral infections, such as lenge. However, this population of AFCs is markedly re-
influenza (Hyland et al., 1994), Sendai (Sangster et al., duced long after the acute viral infection is cleared for
1995), or lymphocytic choriomeningitis (Slifka et al., the life of the animal. These findings thus demonstrate
1995), maintain long-term immunity. The concept that that AFC populations in the spleen and bone marrow
both replicating and nonreplicating antigens can estab- effectively protect for life against repeated viral chal-
lish AFC populations in the bone marrow (Benner et al., lenges.
1981; Tew et al., 1992) is supported by observations of
AFC localization in this compartment after a single immu-
MATERIALS AND METHODSnization with vesicular stomatitis virus, whether live, inac-
tivated, or in a subunit form (Bachmann et al., 1994b). As Vaccine DNA
The pJW4303/H1 vaccine DNA (designated HA DNA)
1 Present address: Quidel Corp, San Diego, CA 92121. consists of the influenza A/PR/8/34 (H1N1) HA gene2 To whom correspondence and reprint requests should be ad-
driven by the CMV immediate-early promoter (Robinsondressed at the Department of Virology and Molecular Biology, St. Jude
et al., 1995). Gold beads coated with the plasmid DNAChildren’s Research Hospital, 332 North Lauderdale Ave., Memphis,
Tennessee 38101-0318. Fax: (901) 523-2622. were injected into the abdominal skin of BALB/c (H-2d)
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mice by use of the Accell II electric discharge DNA gun titration. One to two mice per group were analyzed indi-
vidually at each time point.(Auragen, formerly Agracetus, Middleton, WI). The
pJW44303 control plasmid does not include an HA insert.
Enzyme-linked immunospot (ELISPOT) assays
Virus and HA isolation HA-specific B cell responsiveness was assessed by
the ELISPOT assay. Briefly, 96-well plates (Millipore, Bed-Virus stock of the influenza PR8 (H1N1) strain was
ford, MA) were coated with 5 mg of HA (in 100 ml overnightgrown and purified as described earlier (Skehel and
at 47) from PR8 virus, and after blocking, single-cell sus-Schild, 1971). Both the HA and the neuraminidase were
pensions of lymphoid tissues from individual mice wereextracted from influenza virus particles as described by
added and incubated for 4 hr at 377. HA-specific AFCsJohansson et al. (1989). The relative HA content of the
were detected as spots after the addition of alkalineglycoprotein suspension, expressed as micrograms of
phosphatase-conjugated goat anti-mouse Ig isotype- andHA, was 55%.
IgG subclass-specific reagents and development with 5-
bromo-4-chloro-indolyl phosphate. The number of anti-Mice
body spots was normalized to the number of AFC per
105 cells. The AFC frequencies in the tissues were usedFive- to eight-week-old female BALB/c (H-2d) mice
to compare the relative distribution within the mouse.were purchased from the Jackson Laboratories (Bar Har-
bor, ME) and maintained in pathogen-free conditions fol-
Serologylowing quarantine and during this study.
Sera from mice were tested individually after treatment
DNA vaccination and live virus challenge with receptor-destroying enzyme, and hemagglutination
inhibition (HI) titration of serum was performed as de-The panel of experimental animals used in this study
scribed elsewhere (WHO, 1982). An enzyme-linked im-was divided into three major groups. The first group con-
munosorbent assay (ELISA) was used to determine se-tained mice (5 total) that had been vaccinated with 0.4
rum antibody titers, with fourfold dilutions of the treatedmg of pJW4303/H1, with or without a booster dose 30
sera, and reacted on plates coated with 1 mg of HAdays later, and held separately under pathogen-free con-
from PR8 virus. Phosphatase-labeled Ig isotype- and IgGditions in a biocontainment level 3 (BL3) facility in filter-
subclass-specific reagents, as specified for the ELISPOTtop cages for 350 days. The second group of mice (12
assay, were used with the ELISA, and the reaction wastotal) had been similarly vaccinated with one or two
developed with nitrophenyl phosphate. The serum titerdoses of HA DNA vaccine and challenged intranasally
represents the reciprocal of the highest dilution that gave(i.n.) on Day 45 with 3 LD50 (equivalent to 5 mg of HA)
an absorbance at 405 nm greater than the maximumPR8 virus under Avertin (2,2,2-tribromoethanol) anesthe-
value for negative control serum samples.sia and similarly housed in BL3. Nine of these were
rechallenged on Day 350. The third group were control
Lung virus titer determinationmice (3 total), which received control DNA and remained
unchallenged for the duration of the study. Similar groups Lungs were processed and virus titers determined as
were the subject of earlier analysis of shorter-term mem- described earlier (Allan et al., 1990; Liang et al., 1994).
ory (Days 30 to 58; Justewicz et al., 1995b). All mice
sampled on Days 353 and 358 represent data for Days RESULTS
3 and 8 postchallenge; unchallenged counterparts were
To examine whether immunization with HA DNA in-sampled simultaneously and considered Day 0 samples.
duces B cell memory that is long-lasting and can provide
resistance to challenge at an extended time after vacci-Sampling of mice
nation, we took advantage of vaccinated mice that had
demonstrated protective immunity to influenza within theMice were sampled on Day 350 (no rechallenge) or
Days 353 and 358 (Days 3 and 8 following rechallenge). first 2 months of vaccination, and which were the subject
of our previous report (Justewicz et al., 1995b). Two im-Anesthesized mice were exsanguinated by heart punc-
ture and lymphoid tissues were collected from the upper portant remarks are made here: (i) A relatively small num-
ber of vaccinated mice (17 total) were examined, whichrespiratory (mandibular and superficial cervical lymph
nodes) and lower respiratory (mediastinal lymph nodes) represents those that remained after the initial study and
which survived to 1 year of age and (ii) the immunetracts, the spleen, and the bone marrow. Single-cell sus-
pensions from each tissue sample were prepared in system of aged mice often generates antibodies that are
functionally insufficient (Yang et al., 1996). Despite thesecomplete medium (RPMI 1640 media supplemented with
15% fetal calf serum) and sampled from individual mice points, the findings reported below support our conclu-
sions.on the same day. Lungs were also removed for virus
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tained before initial challenge on Day 45 (Justewicz et
al., 1995b). It should be noted that although these values
are relatively low, they are significant as control mice
lacked HA-specific AFCs entirely. Mice that received HA
DNA but remained unchallenged with PR8 virus lacked
detectable HA-specific AFCs in sites outside the spleen
and bone marrow.
To reveal whether initial live virus challenge enhanced
long-term immunity of HA DNA-vaccinated mice, the
number of HA-specific AFCs was monitored beginning
on Day 350. Compared to unchallenged, vaccinatedFIG. 1. Maintenance of elevated titers of HA-specific IgG antibodies
mice, the number of AFCs in challenged groups re-in serum 350 days after gene-gun vaccination with HA DNA. The influ-
ence of virus rechallenge (arrow, Day 350) on the long-term serum Ig mained constant in the spleen, whereas the numbers
isotype pattern in HA DNA-vaccinated mice was determined. Individual were increased in the bone marrow and mediastinal
symbols represent ELISA titers from mice that were previously chal- nodes on Day 350 (Fig. 2a). Total AFC numbers in the
lenged (closed symbols) that received one (triangles) or two (circles)
bone marrow showed a two- to fourfold increase, to adoses: on Day 350. Three mice were sampled; on Days 353 and 358
level comparable to that in the spleen (Table 1). On the(3 and 8 days postchallenge) the data represent the mean serum titer
for four mice at each time point. Shading shows the increase in serum basis of AFC frequencies, we estimated that 13% of all
titer resulting from challenge on Day 350 in three HA DNA-vaccinated HA-specific AFCs were now localized in the MLN (Fig.
mice that were previously unchallenged. Open squares represent the 2a), while no AFCs were measured in the cervical nodes.
limit of detection of the ELISA assay for each Ig isotype in DNA control
Approximately 60% of all AFCs in these mice were pro-mice. ELISA titer determination was done three times and data are
ducing IgG, with the remainder IgM/ (Fig. 2b). This iso-representative of these experiments.
type profile was identical to that in unchallenged, vacci-
nated mice, indicating that HA DNA vaccination was re-
Maintenance of serum antibodies to HA in mice sponsible for the IgG/ phenotype of the AFC populations.
vaccinated with HA DNA The maintenance of antigen-specific IgG/ AFCs is a dis-
tinct determinant of B cell memory (Bachmann et al.,Mice were bled at 350 days after being vaccinated
1994a,b; Gray, 1992; MacLennan, 1994; Palladino et al.,with 0.4 mg of HA DNA and the sera titrated by ELISA
1995). The findings suggest that long-term populationsand HI. Using the former assay to determine the Ig iso-
of AFCs are maintained in the spleen and bone marrow oftype profile, we found HA-specific IgG, but not IgM or
vaccinated mice, and after virus challenge, an additionalIgA, in the sera of three mice that had received one or
population is preserved in the mediastinal nodes.two doses of vaccine but were never challenged (Fig. 1).
The mean IgG titers (1 1 104.1) were the same whether
AFC localization in response to late rechallenge inthe mice were challenged or not after 2 months (Fig. 1b).
HA DNA-vaccinated miceMoreover, the serum antibodies on Day 350 inhibited
hemagglutination and had titers of 11 103.5, a level equiv-
The experiments reported thus far indicate that aalent to that determined earlier, after challenge on Day
steady-state phase of antibody production exists in HA45. The results indicate that DNA vaccination can main-
DNA-vaccinated mice by Day 350. It was of interest,tain serum antigen-specific antibodies at elevated levels
therefore, to determine whether additional AFCs arefor 1 year, and are consistent with the initial report by
needed to respond to rechallenge. Rechallenge on DayDeck et al. (1995).
350 with 5 mg of HA as live PR8 virus given i.n. provided
the opportunity to examine the shift in AFCs from theLong-term maintenance of HA-specific AFC
spleen and bone marrow to lymphoid tissues drainingpopulations in the spleen and bone marrow of HA
the respiratory tract (cervical and mediastinal nodes).DNA-vaccinated mice.
Within the first 3 days of rechallenge, the frequency and
tissue distribution of HA-specific AFCs was not alteredELISPOT analysis on Day 350 permitted the estimation
of the long-term stability of the HA-specific AFC response appreciably (Table 1). Yet, the total cellularity of the
spleen and bone marrow increased with infection (meanand the population size of these AFCs in the spleen
and bone marrow and in the regional lymph nodes. An of 15%), providing for a threefold increase in AFC num-
bers (Table 1). An increase in size of AFC populationsaverage of 13 ({3) AFCs per 105 cells were present in
the spleen and 3 ({0.6) AFCs per 105 cells in the bone in the cervical and mediastinal nodes was also noted.
In comparison, by 8 days after rechallenge, the ma-marrow. Together, the spleen and bone marrow con-
tained approximately 3 1 103 HA-specific AFCs per jority of HA-specific AFCs was located in the mediasti-
nal nodes (Fig. 2c). These AFCs contributed the mostmouse (Table 1). The AFC frequencies and total numbers
in the two tissues were unchanged from the values ob- to the rise in frequency in these animals, estimated at
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TABLE 1
Long-Term Maintenance of HA-Specific AFCs in the Spleen and Bone Marrow of Mice
Total AFCs/tissueb
Groupa CLN MLN BM Spleen Total/body
Not challenged 0 0 8.6 1 102 2.1 1 103 3.0 1 103
Previously challenged on Day 45 0 2 1 102 1.8 1 103 2.2 1 103 4.2 1 103
Rechallenged on Day 350 3.5 1 102 9.6 1 103 1.4 1 103 6.4 1 103 1.8 1 104
a Mice were immunized twice by gene-gun inoculation with HA DNA followed on Day 45 by i.n. challenge with 3 LD50 of live PR8 (equivalent to
5 mg of HA) or no challenge). Earlier challenged mice were similarly subjected to rechallenge with the same live virus dose. Tissue samples were
collected on Day 350 and 8 days following rechallenge (corresponding to Day 358).
b Total AFC numbers in each tissue were estimated by multiplying the mean AFC frequency (from two mice) by the B cell cellularity of each tissue
at the indicated time points: for the cervical (CLN) and mediastinal (MLN) nodes 50% was assumed (Sarawar and Doherty, 1994), while 30% was
used in estimates for the bone marrow (BM) and spleen (Bachmann et al., 1994b). Tissue distribution and totals in once-immunized mice (two at
each time point) were similar to those shown here at all time points except on Day 8 postrechallenge when the total was approximately 2.5-fold less.
15-fold in the two-dose group (Table 2). This corre- mune mice, required an increase in the total number
of AFCs at the challenge site.sponded to almost a 4-fold increase in the total number
of HA-specific AFCs per mouse (Table 1). Enlargement
Shift in Ig isotype profile of AFCs in response toof the HA-specific AFC population in the mediastinal
rechallenge in HA DNA-vaccinated micenodes coincided with the absence of infectious virus
in the lungs 3 and 8 days after rechallenge, in contrast We next determined whether HA-specific AFCs re-
to virus titers 1 1 103 in naive mice. The contribution mained committed to IgG production in response to re-
by the spleen to the total body count fell from half (on challenge. The Ig isotype profile of HA-specific AFCs in
Day 350) to less than a tenth (Table 2). Thus, protection the mediastinal nodes, spleen, and bone marrow was
against repeated challenge, even in unequivocally im- analyzed, and on Day 3 after rechallenge, the Ig isotype
profile was dominated by IgG/ cells in the spleen and
bone marrow, which was partly due to the relative scar-
city of IgA/ cells in these sites (data not shown). Of
IgG/ cells, the subclass profile was broadened to include
IgG2a in the spleen and all four subclasses (IgG1, IgG2a,
IgG2b, IgG3) in the bone marrow. By Day 8, IgA-secreting
cells replaced the IgM/ population (Fig. 2d), and IgG/
plasma cells remained the majority, producing all four
subclasses but with IgG1 predominating (approximately
65% of total). The predominance of IgG-producing AFCs
is in agreement with the virus-neutralizing properties of
IgG antibodies in response to influenza virus pneumonia
(Palladino et al., 1995).
Correlation of the tissue distribution of AFCs with the
serum Ig isotype profile in mice vaccinated with HA
DNA
We next determined if the Ig isotype and tissue distri-
bution of HA AFCs correlated with the isotype profile of
FIG. 2. Localization of AFCs in cervical and mediastinal lymph nodes HA-specific antibody in the serum. This provided insight
in response to rechallenge in long-term HA DNA-vaccinated mice. HA-
as to whether localized antibody production was re-specific AFC frequencies (per 105 lymphocytes) were determined prior
flected systemically. The ELISA titers shown in Fig. 1,to i.n. rechallenge with 5 mg of HA as live PR8 virus, and 8 days later
(d8c) by ELISPOT assay. The tissue distribution of AFCs (a, c) was derived from the same mice studied by ELISPOT analy-
determined within the cervical (CLN) and mediastinal (MLN) lymph sis, show detectable levels of IgM, IgG, and IgA within
nodes, spleen (Sp), and bone marrow (BM), and was compared with 3 days of rechallenge. On the basis of AFC distribution
the Ig isotype class (IgM, IgG, and IgA) profile (b, d). Frequency data
(Fig. 2), it is clear that the spleen contributes the majorityfrom twice-immunized mice are represented as the means of two to
of IgM antibody in serum. By contrast, serum IgG anti-four replicate platings with tissues from two mice at each sampling
time. body was generated primarily by the bone marrow. The
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TABLE 2
Localization of HA-Specific AFCs in Mice Immunized with HA DNA and Rechallenged
No. of AFCs detected on postchallenge day b
IgM IgG IgA Total Igc
Tissuea 3 8 3 8 3 8 3 8
CLN 0/0 5/1 4/2 5/5 1/3 2/2 5/5 12/8
MLN 5/22 1/2 2/2 192/169 0/0 63/7 7/24 256/178
BM 0/1 1/2 20/10 5/5 3/4 5/5 23/15 11/12
Spleen 22/4 2/4 3/1 15/3 1/2 13/3 26/7 30/10
Total 27/27 9/9 29/15 217/182 5/9 83/17 61/51 309/208
a Mice were immunized twice by gene-gun inoculation with HA DNA followed on Day 45 by i.n. challenge with 3 LD50 of live PR8 (equivalent to
5 mg HA), and rechallenged with the same dose on Day 350, at which time they were monitored by ELISPOT sampling of lymphoid tissues. CLN,
cervical lymph nodes; MLN, mediastinal lymph nodes; BM, bone marrow.
b Postchallenge sampling on Days 3 and 8 corresponds overall to Days 353 and 358, respectively. Each finding is reported as the mean number
of AFCs in tissues from two mice at each time point in the twice-immunized group (mouse 1/mouse 2), normalized to 105 total cells from two to
four replicate platings. Similar results were obtained from two mice at each time point in once-immunized mice. It should be noted that despite
the small number of aged mice available after 1 year, the results are reproducible between animals and the two immunized groups.
c Total Ig represents the sum of AFC frequencies (IgM, IgG, IgA) for each of Day 3 and 8 postchallenge.
rise in serum IgG (Fig. 1b) and IgA (Fig. 1c) antibody ible AFC responsiveness to repeated influenza challenge
indicates the preservation of a repertoire of high-affinityis consistent with an increase in AFC numbers in the
mediastinal nodes. All experimental groups, with the ex- antibodies (and the mechanisms that determine it), par-
ticularly in aged mice.ception of DNA controls, had serum HI antibodies prior
to rechallenge on Day 350 (range 1 1 102.8 to 1 1 103.7).
How does the bone marrow achieve its influentialThese results indicate that the systemic serum Ig profile
role?is a reflection of continued antibody production at differ-
ent anatomic sites.
Our results are in agreement with kinetic studies indi-
cating that AFCs home preferentially to the bone marrow
DISCUSSION
after the infection has been eliminated, so that this ana-
tomic compartment gradually displaces those sites inLong-term maintenance of AFC populations in mice
which the majority of virus-specific plasma cells werevaccinated with HA DNA
initially located, such as the draining lymph nodes and
This study is the first to investigate the anatomical
spleen (Bachmann et al., 1994a,b; Sangster et al., 1995;
localization of long-term AFCs induced by DNA vaccina-
Slifka et al., 1995). It is unlikely that the localization of
tion and the responsiveness to repeated viral challenges
AFCs in bone marrow depends on the infection of this
that are a predictable consequence of influenza in the
tissue (Slifka et al., 1995), rather the cytokine-rich milieu
natural host. We show here that long-term antibody pro-
of this site could be expected to maintain the AFCs that
duction continues for almost 1 year in localized sites
have lodged there after leaving other initially responsive
following exposure to naked plasmid DNA encoding the
sites (Doherty, 1995). As elegantly demonstrated by
influenza virus HA through the use of microprojectile
Bachmann et al. (1994a,b), memory AFCs migrate to but
bombardment. Continued HA-specific antibody produc-
are not generated within the bone marrow, which lacks
tion is primarily the property of IgG-producing AFCs that
antigen. The continued presence of AFCs in the spleens
are found in the bone marrow and spleen. Furthermore,
of DNA-immunized mice demonstrated in this study and
immunity conferred by HA DNA vaccination is highly effi-
elsewhere (Mor et al., 1995) supports the notion that
cient against challenges with live virus, as evidenced by
the maintenance of immunologic memory is the result of
the following: (i) the presence of preexisting IgG antibod-
cooperation between the bone marrow and the activated
ies, (ii) the maintenance of HA-specific AFCs, and (iii) the
secondary lymphoid tissues.
enhanced AFC responsiveness in the mediastinal nodes
and the generation of IgA antibody. The simplest interpre- Is virus challenge necessary to maintain immunity?
tation of these findings is that HA DNA immunization
results in the development of a ‘‘constitutively activated The long-term retention of an appreciable population
of AFCs in the mediastinal nodes of challenged miceenvironment’’ in the bone marrow (Doherty, 1995) with
regard to AFCs. Furthermore, the long-lasting and induc- in the present study cannot be attributed to persistent
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infection of the lungs since they were free of infectious negatively selected to contribute in secondary responses
or to protection against virus challenge. There are differ-virus. Eichelberger et al. (1991) likewise reported the ab-
sence of infectious virus (determined by PCR) in the ences in the subsets of HA-specific AFCs selected by
virus infection in normal mice as opposed to transgeniclungs and surrounding tissues by the 2nd week of infec-
tion. The persistence of AFC populations in lung-associ- mice that express HA as a neo-self antigen (Caton et al.,
1996). Another point of interest is the finding in this studyated lymphoid tissues could reflect a new homeostasis
(Berman et al., 1990; Lipscomb et al., 1995) driven by and elsewhere (Fuller and Haynes, 1994; Mor et al., 1995)
that gene-gun epidermal inoculation of DNA vaccine pre-cells generated from a local memory B cell pool (Bice et
al., 1991, 1993; Fazekas et al., 1994; Jones and Ada, 1986, dominantly favors the development of antibodies of the
IgG1 isotype, which are maintained despite subsequent1987; Lipscomb et al., 1995; Moskophidis et al., 1987),
the development of which is free of the viral burden (Mo viral challenges that normally skew toward an IgG2a phe-
notype (Fazekas et al., 1994; Hocart et al., 1989a,b). Theet al., 1995). Alternatively, the long-term maintenance in
the lungs, and in the spleen and bone marrow, could implication of the IgG1 predominance on the antiviral T
cell response is not clear but virus clearance was effec-result from continued recruitment and maturation of cir-
culating memory B cells as a result of reactivation and/ tive and complete, suggesting that DNA vaccine may
generate CD4/ T helper subsets that are not exclusivelyor perhaps from the existence of long-lived AFCs (Bach-
mann et al., 1994a,b; Ho et al., 1986). Nevertheless, vacci- protective Th1 or nonprotective Th2 (as characterized in
Alwan et al., 1994; Graham et al., 1994). Both T and non-nation with HA DNA alone is sufficient to maintain long-
term AFC responsiveness. T-cell populations are likely to contribute to the local
cytokine profile (Baumgarth et al., 1994; Sarawar and
Doherty, 1995).How does HA DNA compare with conventional
vaccines with regard to long-term protection?
Conclusion
Our findings with HA DNA mimic the immunity estab-
AFC responsiveness that is protective against re-
lished by i.n. infection with live virus in the mouse. For
peated influenza virus challenge is readily maintained
example, Hyland et al. (1994) detected influenza-specific
following immunization with HA DNA.
AFCs 15 months after infection, most of which were dis-
tributed among the spleen, bone marrow, and mediasti-
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